IRCT20210228050535N2
Not yet recruiting
Phase 1
Evaluation of the effect of the autologous exosomes derived from menstrual blood mesenchymal stem cells on implantation rate and prevention of miscarriage in patients with recurrent implantation failure
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mazandaran University of Medical Sciences
- Enrollment
- 44
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women with recurrent implantation failure who did not conceive after at least three embryo transfer cycles or after transferring at least ten good\-quality embryos.
- •Age between 20–40 years
- •With Body Mass Index (BMI) under 30 kg/m2
Exclusion Criteria
- •Uterine abnormalities in hysteroscopy and hysterosalpingography
- •Hematologic disorders
- •Hormonal disorders
- •Immunologic disorders
- •Chromosomal abnormalities and genetic disorders in parents
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Exosome therapy in infertilityDiminished ovarian reserve.Female infertility associated with anovulationN97.0IRCT20210228050535N1Mazandaran University of Medical Sciences30
Recruiting
Phase 1
Exosome and stem cells therapyon-obstructive azoospermia.Male infertilityIRCT20230528058312N2Research assistant for infertility treatment andTahoora limited surgery clinic50
Recruiting
Phase 1
Investigating the safety and efficacy of stem cell exosomes on diabetic foot ulcersDiabetic Foot Ulcer.Type 2 diabetes mellitusIRCT20240317061316N1Qazvin University of Medical Sciences40
Not yet recruiting
Not Applicable
Evaluation of the therapeutic efficiency of the placenta mesenchymal stem cell–derived exosomes on improvement of lung disease symptomsIRCT20130812014333N224Kermanshah University of Medical Sciences10
Completed
Phase 2
Investigation of the effects of the exosomes on patients with COVID-19COVID-19.COVID-19U07.1IRCT20130812014333N164Kermanshah University of Medical Sciences8